You are here

Pfizer, BioNTech plan filing as vaccine proves 95% effective

AK_btpf_1811.jpg
Pfizer said a final analysis of clinical-trial data showed its Covid-19 vaccine was 95 per cent effective, paving the way for the company to apply for the first US regulatory authorisation for a coronavirus shot within days.

[NEW YORK] Pfizer said a final analysis of clinical-trial data showed its Covid-19 vaccine was 95 per cent effective, paving the way for the company to apply for the first US regulatory authorisation for a coronavirus shot within days.

The US drugmaker and partner BioNTech said their...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes